Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-10 06:01 am Purchase | 2026-02-09 | 13D | CASI Pharmaceuticals, Inc. CASI | WEI-WU HE, Ph.D. | 13,965,535 45.400% | 5,000,000 (+55.77%) | Filing History |
| 2026-01-29 7:21 pm Purchase | 2026-01-27 | 13D | CASI Pharmaceuticals, Inc. CASI | WEI-WU HE, Ph.D. | 8,965,535 34.800% | 5,000,000 (+126.09%) | Filing History |
| 2026-01-09 06:03 am Unchanged | 2026-01-09 | 13D | CASI Pharmaceuticals, Inc. CASI | WEI-WU HE, Ph.D. | 3,965,535 19.100% | 0 (Unchanged) | Filing History |
| 2025-12-18 06:01 am Purchase | 2025-12-18 | 13D | CASI Pharmaceuticals, Inc. CASI | WEI-WU HE, Ph.D. | 3,965,535 19.100% | 230,000 (+6.16%) | Filing History |
| 2025-06-20 4:30 pm Purchase | 2025-06-16 | 13D | CASI Pharmaceuticals, Inc. CASI | WEI-WU HE, Ph.D. | 3,735,535 23.800% | 477,644 (+14.66%) | Filing History |
| 2024-08-12 08:27 am Purchase | 2024-07-15 | 13D | CASI Pharmaceuticals, Inc. CASI | WEI-WU HE, Ph.D. | 3,257,891 20.940% | 420,000 (+14.80%) | Filing History |
| 2023-04-18 4:00 pm Purchase | 2023-04-14 | 13D | CASI Pharmaceuticals, Inc. CASI | WEI-WU HE, Ph.D. | 2,837,891 19.750% | 2,837,891 (New Position) | Filing History |
| 2022-06-21 4:26 pm Purchase | 2022-06-13 | 13D | CASI Pharmaceuticals, Inc. CASI | WEI-WU HE, Ph.D. | 2,761,349 18.950% | 2,761,349 (New Position) | Filing History |
| 2021-11-23 5:15 pm Purchase | 2021-11-18 | 13D | CASI Pharmaceuticals, Inc. CASI | WEI-WU HE, Ph.D. | 2,598,199 17.470% | 438,000 (+20.28%) | Filing History |